Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in J Virol

Retrieve available abstracts of 197 articles:
HTML format

Single Articles

    July 2021
  1. MAO R, Dong M, Shen Z, Zhang H, et al
    RNA Helicase DDX17 inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation.
    J Virol. 2021 Jul 21:JVI0044421. doi: 10.1128/JVI.00444.
    PubMed     Abstract available

    June 2021
  2. LIU F, Lee ACH, Guo F, Kondratowicz AS, et al
    Host poly(A) polymerases PAPD5 and PAPD7 provide two layers of protection that ensure the integrity and stability of hepatitis B virus RNA.
    J Virol. 2021 Jun 30:JVI0057421. doi: 10.1128/JVI.00574.
    PubMed     Abstract available

  3. KHATUN M, Zhang J, Ray R, Ray RB, et al
    Hepatitis C virus evades IFN signaling by suppressing long non-coding RNA Linc-Pint involving c/EBP-beta.
    J Virol. 2021 Jun 23:JVI0095221. doi: 10.1128/JVI.00952.
    PubMed     Abstract available

  4. NAKAJIMA S, Watashi K, Kato T, Muramatsu M, et al
    Biochemical and structural properties of entecavir-resistant hepatitis B virus polymerase with L180M/M204V mutations.
    J Virol. 2021 Jun 2:JVI0240120. doi: 10.1128/JVI.02401.
    PubMed     Abstract available

    May 2021
  5. LIU H, Xi J, Hu J
    Regulation of Hepatitis B Virus Replication by Cyclin Docking Motifs in Core Protein.
    J Virol. 2021;95.
    PubMed     Abstract available

  6. VOTH LS, O'Connor JJ, Kerr CM, Doerger E, et al
    Unique mutations in the MHV macrodomain differentially attenuate virus replication, indicating multiple roles for the macrodomain in coronavirus replication.
    J Virol. 2021 May 19. pii: JVI.00766-21. doi: 10.1128/JVI.00766.
    PubMed     Abstract available

  7. IBRAHIM MK, Abdelhafez TH, Takeuchi JS, Wakae K, et al
    MafF is an antiviral host factor that suppresses transcription from Hepatitis B Virus core promoter.
    J Virol. 2021 May 12. pii: JVI.00767-21. doi: 10.1128/JVI.00767.
    PubMed     Abstract available

    April 2021
  8. FU S, Zhang J, Yuan Q, Wang Q, et al
    Lost small envelope protein expression from naturally occurring preS1 deletion mutants of hepatitis B virus is often accompanied by increased HBx and core protein expression as well as genome replication.
    J Virol. 2021 Apr 28. pii: JVI.00660-21. doi: 10.1128/JVI.00660.
    PubMed     Abstract available

  9. REINHARZ V, Ishida Y, Tsuge M, Durso-Cain K, et al
    Understanding hepatitis B virus dynamics and the antiviral effect of interferon-alpha treatment in humanized chimeric mice.
    J Virol. 2021 Apr 28. pii: JVI.00492-20. doi: 10.1128/JVI.00492.
    PubMed     Abstract available

  10. KIM GW, Imam H, Siddiqui A
    The RNA binding proteins YTHDC1 and FMRP regulate the nuclear export of N6-methyladenosine modified Hepatitis B Virus transcripts and affect the viral life cycle.
    J Virol. 2021 Apr 21. pii: JVI.00097-21. doi: 10.1128/JVI.00097.
    PubMed     Abstract available

  11. MCMILLEN CM, Hartman AL
    Rift Valley Fever: a Threat to Pregnant Women Hiding in Plain Sight?
    J Virol. 2021;95.
    PubMed     Abstract available

    March 2021
  12. TEGTMEYER B, Vieyres G, Todt D, Lauber C, et al
    Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elements.
    J Virol. 2021 Mar 3. pii: JVI.00245-21. doi: 10.1128/JVI.00245.
    PubMed     Abstract available

    February 2021
  13. NAM DE, Angelucci A, Choi D, Leigh A, et al
    Elevation of Plasminogen Activator Inhibitor-1 promotes differentiation of Cancer Stem-like Cell state by Hepatitis C Virus infection.
    J Virol. 2021 Feb 24. pii: JVI.02057-20. doi: 10.1128/JVI.02057.
    PubMed     Abstract available

  14. YANG S, Shen Z, Kang Y, Sun L, et al
    A putative amphipathic alpha helix in hepatitis B virus small envelope protein plays a critical role in the morphogenesis of subviral particles.
    J Virol. 2021 Feb 3. pii: JVI.02399-20. doi: 10.1128/JVI.02399.
    PubMed     Abstract available

    January 2021
  15. GLITSCHER M, Himmelsbach K, Woytinek K, Schollmeier A, et al
    Identification of the interferon-inducible GTPase GBP1 as major restriction factor for the Hepatitis E virus.
    J Virol. 2021 Jan 20. pii: JVI.01564-20. doi: 10.1128/JVI.01564.
    PubMed     Abstract available

    December 2020
  16. OROPEZA CE, Tarnow G, Taha TY, Shalaby RE, et al
    Relative DNA methylation and demethylation efficiencies during postnatal liver development regulate hepatitis B virus biosynthesis.
    J Virol. 2020 Dec 23. pii: JVI.02148-20. doi: 10.1128/JVI.02148.
    PubMed     Abstract available

  17. KASAI H, Mochizuki K, Tanaka T, Yamashita A, et al
    Induction of HOX genes by HCV infection via impairment of histone H2A monoubiquitination.
    J Virol. 2020 Dec 16. pii: JVI.01784-20. doi: 10.1128/JVI.01784.
    PubMed     Abstract available

  18. YATO K, Onodera T, Matsuda M, Moriyama S, et al
    Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1.
    J Virol. 2020 Dec 9. pii: JVI.01680-20. doi: 10.1128/JVI.01680.
    PubMed     Abstract available

  19. BAMIA A, Marcato V, Boissiere M, Mansuroglu Z, et al
    The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion.
    J Virol. 2020;95.
    PubMed     Abstract available

    November 2020
  20. YEH YJ, Tseng CP, Hsu SD, Huang HY, et al
    Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection.
    J Virol. 2020 Nov 18. pii: JVI.01800-20. doi: 10.1128/JVI.01800.
    PubMed     Abstract available

  21. DAUSSY CF, Monard SC, Guy C, Munoz-Gonzalez S, et al
    The inflammasome components NLRP3 and ASC act in concert with IRGM to rearrange the Golgi during HCV infection.
    J Virol. 2020 Nov 18. pii: JVI.00826-20. doi: 10.1128/JVI.00826.
    PubMed     Abstract available

  22. GEWAID H, Aoyagi H, Arita M, Watashi K, et al
    Sphingomyelin Is Essential for the Structure and Function of the Double-Membrane Vesicles in Hepatitis C Virus RNA Replication Factories.
    J Virol. 2020;94.
    PubMed     Abstract available

  23. HONG X, Luckenbaugh L, Mendenhall M, Walsh R, et al
    Characterization of Hepatitis B Precore/Core-Related Antigens.
    J Virol. 2020 Nov 4. pii: JVI.01695-20. doi: 10.1128/JVI.01695.
    PubMed     Abstract available

    October 2020
  24. CAI D, Yan R, Xu JZ, Zhang H, et al
    Characterization of the Termini of Cytoplasmic Hepatitis B Virus Deproteinated Relaxed Circular DNA.
    J Virol. 2020 Oct 14. pii: JVI.00922-20. doi: 10.1128/JVI.00922.
    PubMed     Abstract available

    September 2020
  25. WARIS G, Felmlee DJ, Negro F, Siddiqui A, et al
    Retraction for Waris et al., "Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress".
    J Virol. 2020;94.

  26. NASIMUZZAMAN M, Waris G, Mikolon D, Stupack DG, et al
    Retraction for Nasimuzzaman et al., "Hepatitis C Virus Stabilizes Hypoxia-Inducible Factor 1alpha and Stimulates the Synthesis of Vascular Endothelial Growth Factor".
    J Virol. 2020;94.

  27. WARIS G, Siddiqui A
    Retraction for Waris and Siddiqui, "Hepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E2 in RNA Replication".
    J Virol. 2020;94.

  28. WARIS G, Turkson J, Hassanein T, Siddiqui A, et al
    Retraction for Waris et al., "Hepatitis C Virus (HCV) Constitutively Activates STAT-3 via Oxidative Stress: Role of STAT-3 in HCV Replication".
    J Virol. 2020;94.

  29. PIERCE BG, Keck ZY, Wang R, Lau P, et al
    Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization.
    J Virol. 2020 Sep 2. pii: JVI.00704-20. doi: 10.1128/JVI.00704.
    PubMed     Abstract available

    August 2020
  30. CHENG J, Zhao Q, Zhou Y, Tang L, et al
    Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription.
    J Virol. 2020;94.
    PubMed     Abstract available

    July 2020
  31. NGUYEN LP, Nguyen TTT, Nguyen HC, Pham HT, et al
    Cortactin Interacts with Hepatitis C Virus Core and NS5A Proteins: Implications for Virion Assembly.
    J Virol. 2020 Jul 29. pii: JVI.01306-20. doi: 10.1128/JVI.01306.
    PubMed     Abstract available

  32. ABE T, Minami N, Bawono RG, Matsui C, et al
    ISGylation of hepatitis C virus NS5A protein promotes viral RNA replication via the recruitment of cyclophilin A.
    J Virol. 2020 Jul 29. pii: JVI.00532-20. doi: 10.1128/JVI.00532.
    PubMed     Abstract available

  33. CHIANG CH, Lai YL, Huang YN, Yu CC, et al
    Sequential phosphorylation of the HCV NS5A protein depends on NS3-mediated auto-cleavage between NS3 and NS4A.
    J Virol. 2020 Jul 22. pii: JVI.00420-20. doi: 10.1128/JVI.00420.
    PubMed     Abstract available

  34. KWON YC, Sasaki R, Meyer K, Ray R, et al
    Correction for Kwon et al., "Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis".
    J Virol. 2020;94.

    June 2020
  35. TONG Y, Li Q, Li R, Xu Y, et al
    A novel approach to display structural proteins of HCV quasispecies in patients reveals a key role of E2 HVR1 in viral evolution.
    J Virol. 2020 Jun 17. pii: JVI.00622-20. doi: 10.1128/JVI.00622.
    PubMed     Abstract available

  36. PIRACHA ZZ, Saeed U, Kim J, Kwon H, et al
    An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases.
    J Virol. 2020 Jun 3. pii: JVI.00926-20. doi: 10.1128/JVI.00926.
    PubMed     Abstract available

    May 2020
  37. LAI YT, Liou YM, Hsin F, Liu HM, et al
    Genotypic Regulations of Type I Interferon Induction Pathways by the Frame-Shift (F) Proteins of Hepatitis C Virus.
    J Virol. 2020 May 20. pii: JVI.00312-20. doi: 10.1128/JVI.00312.
    PubMed     Abstract available

    April 2020
  38. YANG J, Ma C, Zhao Y, Fan A, et al
    Hepatitis B virus core particles containing a conserved region of the G protein combined with interleukin-35 protected mice against respiratory syncytial virus infection without vaccine-enhanced immunopathology.
    J Virol. 2020 Apr 22. pii: JVI.00007-20. doi: 10.1128/JVI.00007.
    PubMed     Abstract available

    March 2020
  39. MA C, Xu W, Yang Q, Liu W, et al
    Osteopetrosis-Associated Transmembrane Protein 1 Recruits RNA Exosome To Restrict Hepatitis B Virus Replication.
    J Virol. 2020 Mar 18. pii: JVI.01800-19. doi: 10.1128/JVI.01800.
    PubMed     Abstract available

  40. DE BEIJER MTA, Jansen DTSL, Dou Y, van Esch WJE, et al
    Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.
    J Virol. 2020;94.
    PubMed     Abstract available

    February 2020
  41. HARTLAGE AS, Walker CM, Kapoor A
    Priming of antiviral CD8 T cells without effector function by a persistently replicating hepatitis C-like virus.
    J Virol. 2020 Feb 26. pii: JVI.00035-20. doi: 10.1128/JVI.00035.
    PubMed     Abstract available

  42. ZHOU H, Mohlenberg M, Terczynska-Dyla E, Winther KG, et al
    The IFNL4 Gene Is a Noncanonical Interferon Gene with a Unique but Evolutionarily Conserved Regulation.
    J Virol. 2020;94.
    PubMed     Abstract available

    January 2020
  43. KHABIR M, Aliche AZ, Sureau C, Blanchet M, et al
    Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.
    J Virol. 2020;94.
    PubMed     Abstract available

    December 2019
  44. GALLEGO I, Soria ME, Garcia-Crespo C, Chen Q, et al
    Broad and dynamic diversification of infectious hepatitis C virus in a cell culture environment.
    J Virol. 2019 Dec 18. pii: JVI.01856-19. doi: 10.1128/JVI.01856.
    PubMed     Abstract available

  45. NGUYEN LP, Tran SC, Suetsugu S, Lim YS, et al
    PACSIN2 Interacts with Nonstructural 5A Protein and Regulates Hepatitis C Virus Assembly.
    J Virol. 2019 Dec 4. pii: JVI.01531-19. doi: 10.1128/JVI.01531.
    PubMed     Abstract available

    November 2019
  46. SUNG VM, Lai MMC
    Retraction for Sung and Lai, "Murine Retroviral Pseudotype Virus Containing Hepatitis B Virus Large and Small Surface Antigens Confers Specific Tropism for Primary Human Hepatocytes: a Potential Liver-Specific Targeting System".
    J Virol. 2019;93.

  47. SINGH D, Soni S, Khan S, Sarangi AN, et al
    Genome-wide mutagenesis of hepatitis C virus reveals genome ability to overcome detrimental mutations.
    J Virol. 2019 Nov 13. pii: JVI.01327-19. doi: 10.1128/JVI.01327.
    PubMed     Abstract available

    October 2019
  48. KONG L, Aoyagi H, Yang Z, Ouyang T, et al
    Surfeit 4 contributes to the replication of hepatitis C virus using double membrane vesicles.
    J Virol. 2019 Oct 23. pii: JVI.00858-19. doi: 10.1128/JVI.00858.
    PubMed     Abstract available

  49. WU MJ, Shanmugam S, Welsch C, Yi M, et al
    Palmitoylation of the hepatitis C virus NS2 regulates its subcellular localization and NS2-NS3 autocleavage.
    J Virol. 2019 Oct 9. pii: JVI.00906-19. doi: 10.1128/JVI.00906.
    PubMed     Abstract available

    September 2019
  50. VAZQUEZ C, Tan CY, Horner SM
    Hepatitis C virus infection is inhibited by a non-canonical antiviral signaling pathway targeted by NS3-NS4A.
    J Virol. 2019 Sep 18. pii: JVI.00725-19. doi: 10.1128/JVI.00725.
    PubMed     Abstract available

  51. TSAI CN, Pan TC, Chiang CH, Yu CC, et al
    Serine 229 balances the hepatitis C virus nonstructural protein NS5A between hypo- and hyper-phosphorylated states.
    J Virol. 2019 Sep 11. pii: JVI.01028-19. doi: 10.1128/JVI.01028.
    PubMed     Abstract available

  52. WANG H, Tai AW
    Nir2 is an effector of VAPs necessary for efficient HCV replication and PI(4)P enrichment at the viral replication organelle.
    J Virol. 2019 Sep 4. pii: JVI.00742-19. doi: 10.1128/JVI.00742.
    PubMed     Abstract available

    August 2019
  53. JOHNSON J, Freedman H, Logan M, Wong JAJ, et al
    A recombinant HCV genotype 1a E1/E2 envelope glycoprotein vaccine elicits antibodies that differentially neutralize closely related 2a strains through interactions of the N-terminal hypervariable region 1 of E2 with scavenger receptor B1.
    J Virol. 2019 Aug 28. pii: JVI.00810-19. doi: 10.1128/JVI.00810.
    PubMed     Abstract available

  54. CHEN TI, Hsu YK, Chou CY, Chen YH, et al
    Hepatitis C Virus NS3 Protein Plays a Dual Role in WRN-Mediated Repair of Non-Homologous End Joining.
    J Virol. 2019 Aug 28. pii: JVI.01273-19. doi: 10.1128/JVI.01273.
    PubMed     Abstract available

  55. SHWETHA S, Kumar A, Mullick R, Vasudevan D, et al
    Correction for Shwetha et al., "HuR Displaces Polypyrimidine Tract Binding Protein To Facilitate La Binding to the 3' Untranslated Region and Enhances Hepatitis C Virus Replication".
    J Virol. 2019;93.

  56. HU J, Protzer U, Siddiqui A
    Revisiting Hepatitis B virus: Challenges of Curative Therapies.
    J Virol. 2019 Aug 2. pii: JVI.01032-19. doi: 10.1128/JVI.01032.
    PubMed     Abstract available

    July 2019
  57. SZKOLNICKA D, Pollan A, Da Silva N, Oechslin N, et al
    Recombinant Hepatitis E Viruses Harboring Tags in the ORF1 Protein.
    J Virol. 2019 Jul 17. pii: JVI.00459-19. doi: 10.1128/JVI.00459.
    PubMed     Abstract available

  58. SCHULT P, Nattermann M, Lauber C, Seitz S, et al
    Evidence for internal initiation of RNA synthesis by the Hepatitis C virus RNA-dependent RNA polymerase NS5B in cellulo.
    J Virol. 2019 Jul 17. pii: JVI.00525-19. doi: 10.1128/JVI.00525.
    PubMed     Abstract available

  59. MEKONNEN ZA, Grubor-Bauk B, English K, Leung P, et al
    Single dose vaccination with a hepatotropic Adeno-associated virus (AAV) efficiently localises T cell immunity in the liver with the potential to confer rapid protection against hepatitis C virus (HCV).
    J Virol. 2019 Jul 10. pii: JVI.00202-19. doi: 10.1128/JVI.00202.
    PubMed     Abstract available

  60. WOLFISBERG R, Holmbeck K, Nielsen L, Kapoor A, et al
    Replicons of a rodent hepatitis C model virus permit selection of highly permissive cells.
    J Virol. 2019 Jul 10. pii: JVI.00733-19. doi: 10.1128/JVI.00733.
    PubMed     Abstract available

    June 2019
  61. PATRA T, Sasaki R, Meyer K, Ray RB, et al
    TGF-beta acts as a regulatory molecule for lipogenic pathway among hepatitis C virus genotype specific infection.
    J Virol. 2019 Jun 26. pii: JVI.00811-19. doi: 10.1128/JVI.00811.
    PubMed     Abstract available

  62. KORNYEYEV D, Ramakrishnan D, Voitenleitner C, Livingston CM, et al
    Spatiotemporal Analysis of Hepatitis B Virus X Protein in Primary Human Hepatocytes.
    J Virol. 2019 Jun 5. pii: JVI.00248-19. doi: 10.1128/JVI.00248.
    PubMed     Abstract available

  63. RAMAKRISHNAN D, Xing W, Beran RK, Chemuru S, et al
    Hepatitis B Virus X Protein Function Requires Zinc Binding.
    J Virol. 2019 Jun 5. pii: JVI.00250-19. doi: 10.1128/JVI.00250.
    PubMed     Abstract available

  64. COSTAFREDA MI, Kaplan G
    Reply to Das et al., "TIM1 (HAVCR1): an Essential 'Receptor' or an 'Accessory Attachment Factor' for Hepatitis A Virus?"
    J Virol. 2019;93.

  65. DAS A, Maury W, Lemon SM
    TIM1 (HAVCR1): an Essential "Receptor" or an "Accessory Attachment Factor" for Hepatitis A Virus?
    J Virol. 2019;93.

    May 2019
  66. INOUE J, Ninomiya M, Umetsu T, Nakamura T, et al
    siRNA Screening for the Small GTPase Rab Proteins Identifies that Rab5B is a Major Regulator of Hepatitis B Virus Production.
    J Virol. 2019 May 22. pii: JVI.00621-19. doi: 10.1128/JVI.00621.
    PubMed     Abstract available

  67. COLBERT MD, Flyak AI, Ogega CO, Kinchen VJ, et al
    Broadly neutralizing antibodies targeting new sites of vulnerability in hepatitis C virus E1E2.
    J Virol. 2019 May 8. pii: JVI.02070-18. doi: 10.1128/JVI.02070.
    PubMed     Abstract available

  68. QIN Y, Xun Z, Guo Y, Chen S, et al
    Sam68 Promotes Hepatitis C Virus Replication by Interaction with Stem-Loop 2 of Viral 5' Untranslated Region.
    J Virol. 2019 May 8. pii: JVI.00693-19. doi: 10.1128/JVI.00693.
    PubMed     Abstract available

  69. ZHAO Z, Wang JC, Gonzalez-Gutierrez G, Venkatakrishnan B, et al
    Structural differences between the Woodchuck hepatitis virus core protein in dimer and capsid states are consistent with entropic and conformational regulation of assembly.
    J Virol. 2019 May 1. pii: JVI.00141-19. doi: 10.1128/JVI.00141.
    PubMed     Abstract available

    April 2019
  70. MITRA B, Wang J, Kim ES, Mao R, et al
    Hepatitis B Virus Precore Protein p22 Inhibits Interferon-alpha Signaling by Blocking STAT Nuclear Translocation.
    J Virol. 2019 Apr 24. pii: JVI.00196-19. doi: 10.1128/JVI.00196.
    PubMed     Abstract available

  71. PROUDFOOT A, Hyrina A, Holdorf M, Frank AO, et al
    First Crystal Structure of a Non-Structural Hepatitis E Viral Protein Identifies a Putative Novel Zinc-Binding Protein.
    J Virol. 2019 Apr 24. pii: JVI.00170-19. doi: 10.1128/JVI.00170.
    PubMed     Abstract available

    March 2019
  72. LI H, Fan M, Liu B, Ji P, et al
    Chicken organic anion transporting polypeptide 1A2, a novel avian hepatitis E virus (HEV) ORF2-interacting protein, is involved in avian HEV infection.
    J Virol. 2019 Mar 20. pii: JVI.02205-18. doi: 10.1128/JVI.02205.
    PubMed     Abstract available

  73. YAO Y, Yang B, Chen Y, Wang H, et al
    RNA-Binding Motif Protein 24 (RBM24) Is Involved in Pregenomic RNA Packaging by Mediating Interaction between Hepatitis B Virus Polymerase and the Epsilon Element.
    J Virol. 2019;93.
    PubMed     Abstract available

  74. DENG L, Gan X, Ito M, Chen M, et al
    Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.
    J Virol. 2019;93.
    PubMed     Abstract available

  75. SAEED U, Kim J, Piracha ZZ, Kwon H, et al
    Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
    J Virol. 2019;93.
    PubMed     Abstract available

  76. SHERAZ M, Cheng J, Tang L, Chang J, et al
    Cellular DNA topoisomerases are required for the synthesis of hepatitis B virus covalently closed circular DNA.
    J Virol. 2019 Mar 13. pii: JVI.02230-18. doi: 10.1128/JVI.02230.
    PubMed     Abstract available

  77. SAHUC ME, Sahli R, Riviere C, Pene V, et al
    Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus Is a New Inhibitor of Hepatitis C Virus RNA Replication.
    J Virol. 2019 Mar 6. pii: JVI.02009-18. doi: 10.1128/JVI.02009.
    PubMed     Abstract available

  78. TAKEUCHI JS, Fukano K, Iwamoto M, Tsukuda S, et al
    A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity.
    J Virol. 2019;93.
    PubMed     Abstract available

    February 2019
  79. FLECKEN T, Meier MA, Skewes-Cox P, Barkan DT, et al
    Mapping the heterogeneity of histone modifications on hepatitis B virus-DNA using liver needle biopsies obtained from chronically infected patients.
    J Virol. 2019 Feb 20. pii: JVI.02036-18. doi: 10.1128/JVI.02036.
    PubMed     Abstract available

  80. KHAKPOOR A, Ni Y, Chen A, Ho ZZ, et al
    Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
    J Virol. 2019;93.
    PubMed     Abstract available

  81. BANG BR, Li M, Tsai KN, Aoyagi H, et al
    Regulation of HCV infection by Cellular Retinoic Acid Binding Proteins through the modulation of lipid droplet abundance.
    J Virol. 2019 Feb 6. pii: JVI.02302-18. doi: 10.1128/JVI.02302.
    PubMed     Abstract available

  82. HARICHANDRAN K, Shen Y, Tsoris SS, Lee SC, et al
    Hepatitis Delta Antigen Regulates mRNA and Antigenome RNA Levels during Hepatitis Delta Virus Replication.
    J Virol. 2019 Feb 6. pii: JVI.01989-18. doi: 10.1128/JVI.01989.
    PubMed     Abstract available

    January 2019
  83. WANG L, Teng JL, Lau SKP, Sridhar S, et al
    Transmission of A Novel Genotype Hepatitis E Virus from Bactrian Camels to Cynomolgus Macaques.
    J Virol. 2019 Jan 30. pii: JVI.02014-18. doi: 10.1128/JVI.02014.
    PubMed     Abstract available

  84. YANG Q, Zhang Q, Zhang X, You L, et al
    HoxA10 Facilitates SHP-1-catalized Dephosphorylation of p38 MAPK/STAT3 to Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.
    J Virol. 2019 Jan 23. pii: JVI.01607-18. doi: 10.1128/JVI.01607.
    PubMed     Abstract available

  85. MARIN MQ, Perez P, Ljungberg K, Sorzano COS, et al
    Potent Anti-Hepatitis C (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-launched RNA Replicons and MVA-HCV.
    J Virol. 2019 Jan 23. pii: JVI.00055-19. doi: 10.1128/JVI.00055.
    PubMed     Abstract available

  86. URBANOWICZ RA, Wang R, Schiel JE, Keck ZY, et al
    Antigenicity and Immunogenicity of Differentially Glycosylated HCV E2 Envelope Proteins Expressed in Mammalian and Insect Cells.
    J Virol. 2019 Jan 16. pii: JVI.01403-18. doi: 10.1128/JVI.01403.
    PubMed     Abstract available

  87. KUSAKABE S, Suzuki T, Sugiyama Y, Haga S, et al
    USP15 participates in HCV propagation through the regulation of viral RNA translation and lipid droplet formation.
    J Virol. 2019 Jan 9. pii: JVI.01708-18. doi: 10.1128/JVI.01708.
    PubMed     Abstract available

    December 2018
  88. LEBSIR N, Goueslain L, Farhat R, Callens N, et al
    Functional and physical interaction between the Arf activator GBF1 and hepatitis C virus NS3 protein.
    J Virol. 2018 Dec 19. pii: JVI.01459-18. doi: 10.1128/JVI.01459.
    PubMed     Abstract available

  89. MOSHKANI S, Chiale C, Lang SM, Rose JK, et al
    A highly attenuated vesicular stomatitis virus-based vaccine platform controls HBV replication in mouse models of hepatitis B.
    J Virol. 2018 Dec 12. pii: JVI.01586-18. doi: 10.1128/JVI.01586.
    PubMed     Abstract available

  90. JACQUET S, Pons JB, De Bernardo A, Ngoubangoye B, et al
    Evolution of Hepatitis B Virus Receptor NTCP Reveals Differential Pathogenicity and Species-Specificities of Hepadnaviruses in Primates, Rodents and Bats.
    J Virol. 2018 Dec 12. pii: JVI.01738-18. doi: 10.1128/JVI.01738.
    PubMed     Abstract available

    November 2018
  91. VELAZQUEZ-MOCTEZUMA R, Galli A, Law M, Bukh J, et al
    Hepatitis C virus escape studies for human antibody AR3A reveals a high barrier to resistance and novel insights on viral antibody evasion mechanisms.
    J Virol. 2018 Nov 28. pii: JVI.01909-18. doi: 10.1128/JVI.01909.
    PubMed     Abstract available

  92. CAPELLI N, Marion O, Dubois M, Allart S, et al
    Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.
    J Virol. 2018 Nov 21. pii: JVI.01207-18. doi: 10.1128/JVI.01207.
    PubMed     Abstract available

  93. WANG Y, Cui L, Yang G, Zhan J, et al
    Hepatitis B e antigen inhibits NF-kappaB activity by interrupting K63-linked ubiquitination of NEMO.
    J Virol. 2018 Nov 7. pii: JVI.00667-18. doi: 10.1128/JVI.00667.
    PubMed     Abstract available

  94. MURATA Y, Kawashima K, Sheikh K, Tanaka Y, et al
    Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8(+) T Cell Responses.
    J Virol. 2018;92.
    PubMed     Abstract available

    October 2018
  95. PHAM HT, Nguyen TTT, Nguyen LP, Han SS, et al
    Hepatitis C virus downregulates ubiquitin conjugating enzyme E2S expression to prevent proteasomal degradation of NS5A, leading to host cells more sensitive to DNA damage.
    J Virol. 2018 Oct 31. pii: JVI.01240-18. doi: 10.1128/JVI.01240.
    PubMed     Abstract available

  96. YI DR, An N, Liu ZL, Xu FW, et al
    Human MxB inhibits the replication of HCV.
    J Virol. 2018 Oct 17. pii: JVI.01285-18. doi: 10.1128/JVI.01285.
    PubMed     Abstract available

  97. BAI L, Zhang X, Li W, Wu M, et al
    Extracellular HBV RNAs are heterogeneous in length and circulate as capsid-antibody-complexes in addition to virions in chronic hepatitis B patients.
    J Virol. 2018 Oct 3. pii: JVI.00798-18. doi: 10.1128/JVI.00798.
    PubMed     Abstract available

    September 2018
  98. SCHENK C, Meyrath M, Warnken U, Schnolzer M, et al
    Characterization of a threonine-rich cluster in Hepatitis C virus nonstructural protein 5A and its contribution to hyperphosphorylation.
    J Virol. 2018 Sep 26. pii: JVI.00737-18. doi: 10.1128/JVI.00737.
    PubMed     Abstract available

  99. DOMINGUEZ-MOLINA B, Machmach K, Perales C, Tarancon-Diez L, et al
    Toll Like Receptor-7 and -9 agonists improve Hepatitis C Virus replication and infectivity inhibition by plasmacytoid dendritic cells.
    J Virol. 2018 Sep 19. pii: JVI.01219-18. doi: 10.1128/JVI.01219.
    PubMed     Abstract available

  100. QIAO L, Sui J, Luo G
    Robust human and murine hepatocyte culture models of hepatitis B virus infection and replication.
    J Virol. 2018 Sep 19. pii: JVI.01255-18. doi: 10.1128/JVI.01255.
    PubMed     Abstract available

  101. QU B, Ni Y, Lempp FA, Vondran FWR, et al
    T5 exonuclease hydrolysis of Hepatitis B Virus replicative intermediates allows reliable quantification and fast drug efficacy testing of covalently closed circular DNA by PCR.
    J Virol. 2018 Sep 19. pii: JVI.01117-18. doi: 10.1128/JVI.01117.
    PubMed     Abstract available

  102. GONZALEZ-LOPEZ O, Rivera-Serrano EE, Hu F, Hensley L, et al
    Redundant late domain functions of tandem VP2 YPX3L motifs in nonlytic cellular egress of quasi-enveloped hepatitis A virus.
    J Virol. 2018 Sep 19. pii: JVI.01308-18. doi: 10.1128/JVI.01308.
    PubMed     Abstract available

  103. WU SX, Chen WN, Jing ZT, Liu W, et al
    Hepatitis B spliced protein (HBSP) suppresses Fas-mediated hepatocyte apoptosis via activation of PI3K/Akt signaling.
    J Virol. 2018 Sep 12. pii: JVI.01273-18. doi: 10.1128/JVI.01273.
    PubMed     Abstract available

  104. KAWASHIMA K, Isogawa M, Hamada-Tsutsumi S, Baudi I, et al
    Type I interferon signaling prevents hepatitis B virus-specific T cell responses by reducing antigen expression.
    J Virol. 2018 Sep 12. pii: JVI.01099-18. doi: 10.1128/JVI.01099.
    PubMed     Abstract available

  105. BOEIJEN LL, Hou J, de Groen RA, Verbon A, et al
    Persistent replication of HIV, HCV and HBV results in distinct gene expression profiles by human NK cells.
    J Virol. 2018 Sep 5. pii: JVI.00575-18. doi: 10.1128/JVI.00575.
    PubMed     Abstract available

  106. XIE Q, Chen S, Tian R, Huang X, et al
    Long Noncoding RNA ITPRIP-1 Positively Regulates the Innate Immune Response through Promotion of Oligomerization and Activation of MDA5.
    J Virol. 2018;92.
    PubMed     Abstract available

    August 2018
  107. PIRACHA ZZ, Kwon HJ, Saeed U, Kim J, et al
    Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis via the AKT/GSK-3beta/beta-Catenin Signaling Pathway.
    J Virol. 2018 Aug 15. pii: JVI.00955-18. doi: 10.1128/JVI.00955.
    PubMed     Abstract available

  108. YUGO DM, Heffron CL, Ryu J, Uh K, et al
    Infection dynamics of hepatitis E virus in wild-type and immunoglobulin heavy chain knockout JH (-/-) gnotobiotic piglets.
    J Virol. 2018 Aug 15. pii: JVI.01208-18. doi: 10.1128/JVI.01208.
    PubMed     Abstract available

  109. ZHAO Y, Cao X, Guo M, Wang X, et al
    NEURL3 is an inducible antiviral effector to inhibit HCV assembly by targeting viral E1 glycoprotein.
    J Virol. 2018 Aug 15. pii: JVI.01123-18. doi: 10.1128/JVI.01123.
    PubMed     Abstract available

  110. SUR S, Sasaki R, Devhare P, Steele R, et al
    Association between microRNA-373 and long non-coding RNA NORAD in hepatitis C virus infected hepatocytes impairs Wee1 expression for growth promotion.
    J Virol. 2018 Aug 8. pii: JVI.01215-18. doi: 10.1128/JVI.01215.
    PubMed     Abstract available

  111. HSU SC, Tsai CN, Lee KY, Pan TC, et al
    Sequential S232/S235/S238 Phosphorylation of the Hepatitis C Virus Nonstructural Protein 5A.
    J Virol. 2018 Aug 8. pii: JVI.01295-18. doi: 10.1128/JVI.01295.
    PubMed     Abstract available

  112. RUAN L, Hadden JA, Zlotnick A
    Assembly properties of Hepatitis B Virus core protein mutants correlate with their resistance to assembly-directed antivirals.
    J Virol. 2018 Aug 8. pii: JVI.01082-18. doi: 10.1128/JVI.01082.
    PubMed     Abstract available

  113. ANANG S, Kaushik N, Hingane S, Kumari A, et al
    Potent inhibition of hepatitis E virus release by a cyclic peptide inhibitor of the interaction between viral open reading frame 3 protein and host tumor susceptibility gene 101.
    J Virol. 2018 Aug 1. pii: JVI.00684-18. doi: 10.1128/JVI.00684.
    PubMed     Abstract available

  114. MOUSTAFA RI, Haddad JG, Linna L, Hanoulle X, et al
    Functional study of the C-terminal part of hepatitis C virus E1 ectodomain.
    J Virol. 2018 Aug 1. pii: JVI.00939-18. doi: 10.1128/JVI.00939.
    PubMed     Abstract available

    July 2018
  115. NYSTROM K, Wanrooij PH, Waldenstrom J, Adamek L, et al
    J Virol. 2018 Jul 25. pii: JVI.01087-18. doi: 10.1128/JVI.01087.
    PubMed     Abstract available

  116. XIA Y, Cheng X, Li Y, Valdez K, et al
    Hepatitis B virus deregulates cell cycle to promote viral replication and a premalignant phenotype.
    J Virol. 2018 Jul 18. pii: JVI.00722-18. doi: 10.1128/JVI.00722.
    PubMed     Abstract available

    June 2018
  117. ZHANG Y, Wu Y, Deng M, Xu D, et al
    CD8(+) T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress.
    J Virol. 2018 Jun 27. pii: JVI.02120-17. doi: 10.1128/JVI.02120.
    PubMed     Abstract available

  118. LEE AR, Lim KH, Park ES, Kim DH, et al
    Multiple functions of c-FLIP are essential for replication of hepatitis B virus.
    J Virol. 2018 Jun 6. pii: JVI.00339-18. doi: 10.1128/JVI.00339.
    PubMed     Abstract available

  119. LI P, Shan Y, Zheng W, Ou X, et al
    Identification of H209 as Essential for pH 8-Triggered Receptor-Independent Syncytium Formation by S Protein of Mouse Hepatitis Virus A59.
    J Virol. 2018;92.
    PubMed     Abstract available

    May 2018
  120. ABDUL F, Filleton F, Gerossier L, Paturel A, et al
    Smc5/6 Antagonism by HBx Is an Evolutionarily Conserved Function of Hepatitis B Virus Infection in Mammals.
    J Virol. 2018 May 30. pii: JVI.00769-18. doi: 10.1128/JVI.00769.
    PubMed     Abstract available

  121. LEE J, Zong L, Krotow A, Qin Y, et al
    N-linked glycosylation is not essential for sodium taurocholate cotransporting polypeptide to mediate hepatitis B virus infection in vitro.
    J Virol. 2018 May 23. pii: JVI.00732-18. doi: 10.1128/JVI.00732.
    PubMed     Abstract available

  122. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Correction for Belouzard et al., "Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes".
    J Virol. 2018;92.

  123. FREITAS N, Lukash T, Gunewardena S, Chappell B, et al
    Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.
    J Virol. 2018;92.
    PubMed     Abstract available

  124. NAIR S, Zlotnick A
    Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    J Virol. 2018;92.
    PubMed     Abstract available

  125. NING X, Luckenbaugh L, Liu K, Bruss V, et al
    Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-free Hepatitis B Virions.
    J Virol. 2018 May 9. pii: JVI.00272-18. doi: 10.1128/JVI.00272.
    PubMed     Abstract available

    April 2018
  126. KIM JY, Ou JJ
    Regulation of Apolipoprotein E Trafficking by Hepatitis C Virus-induced Autophagy.
    J Virol. 2018 Apr 25. pii: JVI.00211-18. doi: 10.1128/JVI.00211.
    PubMed     Abstract available

  127. DE OLIVEIRA CARNEIRO I, Sander AL, Silva N, Moreira-Soto A, et al
    A novel marsupial hepatitis A virus corroborates complex evolutionary patterns shaping the genus Hepatovirus.
    J Virol. 2018 Apr 25. pii: JVI.00082-18. doi: 10.1128/JVI.00082.
    PubMed     Abstract available

  128. MATSUI C, Deng L, Minami N, Abe T, et al
    Hepatitis C virus NS5A protein promotes the lysosomal degradation of hepatocyte nuclear factor 1alpha via chaperone-mediated autophagy.
    J Virol. 2018 Apr 25. pii: JVI.00639-18. doi: 10.1128/JVI.00639.
    PubMed     Abstract available

  129. KARIMZADEH H, Kiraithe MM, Kosinska AD, Glaser M, et al
    Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells.
    J Virol. 2018 Apr 18. pii: JVI.01891-17. doi: 10.1128/JVI.01891.
    PubMed     Abstract available

  130. CHEN Y, Liu B, Sun Y, Li H, et al
    Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
    J Virol. 2018 Apr 18. pii: JVI.00251-18. doi: 10.1128/JVI.00251.
    PubMed     Abstract available

  131. ZHAO Q, Hu Z, Cheng J, Wu S, et al
    Hepatitis B virus core protein dephosphorylation occurs during pregenomic RNA encapsidation.
    J Virol. 2018 Apr 18. pii: JVI.02139-17. doi: 10.1128/JVI.02139.
    PubMed     Abstract available

  132. IQBAL J, Sarkar-Dutta M, McRae S, Ramachandran A, et al
    Osteopontin regulates HCV replication and assembly via interaction with HCV proteins and lipid droplets and by binding to receptors, alphaVbeta3 and CD44.
    J Virol. 2018 Apr 18. pii: JVI.02116-17. doi: 10.1128/JVI.02116.
    PubMed     Abstract available

    March 2018
  133. AUNINS TR, Marsh KA, Subramanya G, Uprichard SL, et al
    Intracellular hepatitis C modeling predicts infection dynamics and viral protein mechanisms.
    J Virol. 2018 Mar 21. pii: JVI.02098-17. doi: 10.1128/JVI.02098.
    PubMed     Abstract available

  134. NGUYEN TT, Park EM, Lim YS, Hwang SB, et al
    Nonstructural 5A impairs DNA damage repair: Implication of hepatitis C virus-mediated hepatocarcinogenesis.
    J Virol. 2018 Mar 21. pii: JVI.00178-18. doi: 10.1128/JVI.00178.
    PubMed     Abstract available

  135. NISHITSUJI H, Ujino S, Harada K, Shimotohno K, et al
    TIP60 Complex Inhibits Hepatitis B Virus Transcription.
    J Virol. 2018;92.
    PubMed     Abstract available

  136. HALDIPUR B, Bhukya PL, Arankalle V, Lole K, et al
    Positive regulation of hepatitis E virus replication by microRNA-122.
    J Virol. 2018 Mar 14. pii: JVI.01999-17. doi: 10.1128/JVI.01999.
    PubMed     Abstract available

  137. LAW JLM, Logan M, Wong J, Kundu J, et al
    Role of the E2 hypervariable region (HVR1) in the immunogenicity of a recombinant HCV vaccine.
    J Virol. 2018 Mar 14. pii: JVI.02141-17. doi: 10.1128/JVI.02141.
    PubMed     Abstract available

  138. SUFFNER S, Gerstenberg N, Patra M, Ruibal P, et al
    Domains of the hepatitis B virus small surface protein S mediating oligomerization.
    J Virol. 2018 Mar 14. pii: JVI.02232-17. doi: 10.1128/JVI.02232.
    PubMed     Abstract available

    February 2018
  139. RIVA L, Song OR, Prentoe J, Helle F, et al
    J Virol. 2018 Feb 28. pii: JVI.01982-17. doi: 10.1128/JVI.01982.
    PubMed     Abstract available

  140. GU J, Hardy J, Boo I, Vietheer P, et al
    Escape of Hepatitis C virus from epitope I neutralization increases sensitivity of other neutralization epitopes.
    J Virol. 2018 Feb 21. pii: JVI.02066-17. doi: 10.1128/JVI.02066.
    PubMed     Abstract available

  141. MOUSTAFA S, Karakasiliotis I, Mavromara P
    Hepatitis C virus core+1/ARFP modulates Cyclin D1/pRb pathway and promotes carcinogenesis.
    J Virol. 2018 Feb 14. pii: JVI.02036-17. doi: 10.1128/JVI.02036.
    PubMed     Abstract available

  142. COSTAFREDA MI, Kaplan G
    HAVCR1 (CD365) and its mouse ortholog are functional hepatitis A virus (HAV) cellular receptors that mediate HAV infection.
    J Virol. 2018 Feb 7. pii: JVI.02065-17. doi: 10.1128/JVI.02065.
    PubMed     Abstract available

  143. SHIMIZU Y, Shirasago Y, Kondoh M, Suzuki T, et al
    Monoclonal antibodies against occludin completely prevented hepatitis C virus infection in a mouse model.
    J Virol. 2018 Feb 7. pii: JVI.02258-17. doi: 10.1128/JVI.02258.
    PubMed     Abstract available

  144. WIJESUNDARA DK, Gummow J, Li Y, Yu W, et al
    Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice.
    J Virol. 2018 Feb 7. pii: JVI.02133-17. doi: 10.1128/JVI.02133.
    PubMed     Abstract available

  145. TU T, Budzinska MA, Vondran FWR, Shackel NA, et al
    Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via NTCP-dependent uptake of enveloped virus particles.
    J Virol. 2018 Feb 7. pii: JVI.02007-17. doi: 10.1128/JVI.02007.
    PubMed     Abstract available

  146. SONG M, Sun Y, Tian J, He W, et al
    Silencing Retinoid X Receptor Alpha Expression Enhances Early-stage Hepatitis B Virus Infection In Cell Cultures.
    J Virol. 2018 Feb 7. pii: JVI.01771-17. doi: 10.1128/JVI.01771.
    PubMed     Abstract available

  147. WONDERLICH ER, Caroline AL, McMillen CM, Walters AW, et al
    Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.
    J Virol. 2018;92.
    PubMed     Abstract available

    January 2018
  148. LI Q, Tong Y, Xu Y, Niu J, et al
    Genetic Analysis of Serum-derived HCV Defective Genomes Revealed Novel Viral Cis-Elements for Virus Replication and Assembly.
    J Virol. 2018 Jan 24. pii: JVI.02182-17. doi: 10.1128/JVI.02182.
    PubMed     Abstract available

  149. DORING T, Zeyen L, Bartusch C, Prange R, et al
    Hepatitis B Virus Subverts the Autophagy Elongation Complex Atg5-12/16L1 and Does not Require Atg8/LC3 Lipidation for Viral Maturation.
    J Virol. 2018 Jan 24. pii: JVI.01513-17. doi: 10.1128/JVI.01513.
    PubMed     Abstract available

  150. YI G, Wen Y, Shu C, Han Q, et al
    Correction for Yi et al., "Hepatitis C Virus NS4B Can Suppress STING Accumulation To Evade Innate Immune Responses".
    J Virol. 2018;92.

  151. DUAN X, Li S, Holmes JA, Tu Z, et al
    MicroRNA-130a regulates both HCV and HBV replication through a central metabolic pathway.
    J Virol. 2018 Jan 10. pii: JVI.02009-17. doi: 10.1128/JVI.02009.
    PubMed     Abstract available

  152. KANADE GD, Pingale KD, Karpe YA
    Activities of Thrombin and Factor Xa are essential for replication of Hepatitis E virus and are possibly implicated in the ORF1 polyprotein processing.
    J Virol. 2018 Jan 10. pii: JVI.01853-17. doi: 10.1128/JVI.01853.
    PubMed     Abstract available

  153. KACHKO A, Costafreda MI, Zubkova I, Jacques J, et al
    Determinants in the IgV Domain of human HAVCR1 (TIM-1) are required to enhance Hepatitis C Virus Entry.
    J Virol. 2018 Jan 10. pii: JVI.01742-17. doi: 10.1128/JVI.01742.
    PubMed     Abstract available

    December 2017
  154. KWEI K, Tang X, Lok AS, Sureau C, et al
    Correction for Kwei et al., "Impaired Virion Secretion by Hepatitis B Virus Immune Escape Mutants and Its Rescue by Wild-Type Envelope Proteins or a Second-Site Mutation".
    J Virol. 2017;91.

  155. YANG Z, Wang X, Chi X, Zhao F, et al
    Correction for Yang et al., "Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection".
    J Virol. 2017;91.

  156. KIM H, Bose SK, Meyer K, Ray R, et al
    Correction for Kim et al., "Hepatitis C Virus Impairs Natural Killer Cell-Mediated Augmentation of Complement Synthesis".
    J Virol. 2017;91.

  157. BEILSTEIN F, Blanchet M, Vaillant A, Sureau C, et al
    Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.
    J Virol. 2017 Dec 6. pii: JVI.01416-17. doi: 10.1128/JVI.01416.
    PubMed     Abstract available

  158. DIXIT U, Pandey AK, Liu Z, Kumar S, et al
    Correction for Dixit et al., "FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53".
    J Virol. 2017;91.

    November 2017
  159. PAUL D, Madan V, Ramirez O, Bencun M, et al
    Glycine-zipper motifs in hepatitis C virus nonstructural protein 4B are required for the establishment of viral replication organelles.
    J Virol. 2017 Nov 22. pii: JVI.01890-17. doi: 10.1128/JVI.01890.
    PubMed     Abstract available

  160. AGARWAL S, Baccam P, Aggarwal R, Veerapu NS, et al
    Novel Synthesis and Phenotypic Analysis of Mutant Clouds for Hepatitis E Virus Genotype 1.
    J Virol. 2017 Nov 22. pii: JVI.01932-17. doi: 10.1128/JVI.01932.
    PubMed     Abstract available

  161. SKARDASI G, Chen AY, Michalak TI
    Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro.
    J Virol. 2017 Nov 22. pii: JVI.01790-17. doi: 10.1128/JVI.01790.
    PubMed     Abstract available

  162. SCHWEITZER CJ, Zhang F, Boyer A, Valdez K, et al
    N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
    J Virol. 2017 Nov 8. pii: JVI.01166-17. doi: 10.1128/JVI.01166.
    PubMed     Abstract available

  163. MORENO-CUBERO E, Subira D, Sanz-de-Villalobos E, Parra-Cid T, et al
    According to HCV infection stage, IL-7 plus 4-1BB triggering alone or combined with PD-1 blockade increases TRAF1low HCV-specific CD8+ cell reactivity.
    J Virol. 2017 Nov 1. pii: JVI.01443-17. doi: 10.1128/JVI.01443.
    PubMed     Abstract available

  164. BRAHMS A, Mudhasani R, Pinkham C, Kota K, et al
    Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway.
    J Virol. 2017;91.
    PubMed     Abstract available

    October 2017
  165. ZHOU T, Ren X, Adams RL, Pyle AM, et al
    NS3 from HCV strain JFH-1 is an unusually robust helicase that is primed to bind and unwind viral RNA.
    J Virol. 2017 Oct 25. pii: JVI.01253-17. doi: 10.1128/JVI.01253.
    PubMed     Abstract available

  166. STOECK IK, Lee JY, Tabata K, Romero-Brey I, et al
    Hepatitis C virus replication depends on endosomal cholesterol homeostasis.
    J Virol. 2017 Oct 18. pii: JVI.01196-17. doi: 10.1128/JVI.01196.
    PubMed     Abstract available

  167. CASE JB, Li Y, Elliott R, Lu X, et al
    Murine hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity.
    J Virol. 2017 Oct 18. pii: JVI.01531-17. doi: 10.1128/JVI.01531.
    PubMed     Abstract available

  168. LI M, Sohn JA, Seeger C
    Distribution of hepatitis B virus nuclear DNA.
    J Virol. 2017 Oct 18. pii: JVI.01391-17. doi: 10.1128/JVI.01391.
    PubMed     Abstract available

    September 2017
  169. QIN Y, Xue B, Liu C, Wang X, et al
    NLRX1 mediates MAVS degradation to attenuate hepatitis C virus-induced innate immune response through PCBP2.
    J Virol. 2017 Sep 27. pii: JVI.01264-17. doi: 10.1128/JVI.01264.
    PubMed     Abstract available

  170. FAUTEUX-DANIEL S, Larouche A, Calderon V, Boulais J, et al
    Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection.
    J Virol. 2017 Sep 20. pii: JVI.01372-17. doi: 10.1128/JVI.01372.
    PubMed     Abstract available

  171. NAGASHIMA S, Takahashi M, Kobayashi T, Tanggis, et al
    The characterization of the quasi-enveloped hepatitis E virus particles released by the cellular exosomal pathway.
    J Virol. 2017 Sep 6. pii: JVI.00822-17. doi: 10.1128/JVI.00822.
    PubMed     Abstract available

    August 2017
  172. KAUSHIK N, Subramani C, Anang S, Muthumohan R, et al
    Zinc salts block Hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase.
    J Virol. 2017 Aug 16. pii: JVI.00754-17. doi: 10.1128/JVI.00754.
    PubMed     Abstract available

  173. LIU N, Zhang J, Yang X, Jiao T, et al
    HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function.
    J Virol. 2017;91.
    PubMed     Abstract available

  174. KWON YC, Sasaki R, Meyer K, Ray R, et al
    J Virol. 2017 Aug 9. pii: JVI.01235-17. doi: 10.1128/JVI.01235.
    PubMed     Abstract available

  175. PIERCE BG, Boucher EN, Piepenbrink KH, Ejemel M, et al
    Structure-Based Design of Hepatitis C Virus Vaccines that Elicit Neutralizing Antibody Responses to a Conserved Epitope.
    J Virol. 2017 Aug 9. pii: JVI.01032-17. doi: 10.1128/JVI.01032.
    PubMed     Abstract available

  176. SHALABY RE, Iram S, Cakal B, Oropeza CE, et al
    J Virol. 2017 Aug 2. pii: JVI.00790-17. doi: 10.1128/JVI.00790.
    PubMed     Abstract available

  177. ZHONG L, Shu W, Dai W, Gao B, et al
    Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.
    J Virol. 2017;91.
    PubMed     Abstract available

    July 2017
  178. KIM JY, Wang L, Lee J, Ou JJ, et al
    HCV induces the localization of lipid rafts to autophagosomes for its RNA replication.
    J Virol. 2017 Jul 26. pii: JVI.00541-17. doi: 10.1128/JVI.00541.
    PubMed     Abstract available

  179. SOORYANARAIN H, Rogers AJ, Cao D, Haac MER, et al
    ISG15 modulates type-I interferon signaling and antiviral response during hepatitis E virus replication.
    J Virol. 2017 Jul 19. pii: JVI.00621-17. doi: 10.1128/JVI.00621.
    PubMed     Abstract available

  180. YIN P, Li Y, Zhang L
    Sec24C-Dependent Transport of Claudin-1 Regulates Hepatitis C Virus Entry.
    J Virol. 2017 Jul 5. pii: JVI.00629-17. doi: 10.1128/JVI.00629.
    PubMed     Abstract available

    June 2017
  181. WELLER R, Hueging K, Brown RJP, Todt D, et al
    Hepatitis C virus strain-dependent usage of apolipoprotein E modulates assembly efficiency and specific infectivity of secreted virions.
    J Virol. 2017 Jun 28. pii: JVI.00422-17. doi: 10.1128/JVI.00422.
    PubMed     Abstract available

  182. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Entry and release of hepatitis C virus in polarized human hepatocytes.
    J Virol. 2017 Jun 28. pii: JVI.00478-17. doi: 10.1128/JVI.00478.
    PubMed     Abstract available

  183. CEVIK RE, Cesarec M, Da Silva Filipe A, Licastro D, et al
    Hepatitis C virus NS5A targets the nucleosome assembly protein NAP1L1 to control the innate cellular response.
    J Virol. 2017 Jun 28. pii: JVI.00880-17. doi: 10.1128/JVI.00880.
    PubMed     Abstract available

  184. LUO J, Cui X, Gao L, Hu J, et al
    Identification of Intermediate in Hepatitis B Virus CCC DNA Formation and Sensitive and Selective CCC DNA Detection.
    J Virol. 2017 Jun 21. pii: JVI.00539-17. doi: 10.1128/JVI.00539.
    PubMed     Abstract available

  185. GOONAWARDANE N, Gebhardt A, Bartlett C, Pichlmair A, et al
    Phosphorylation of serine 225 in hepatitis C virus NS5A regulates protein-protein interactions.
    J Virol. 2017 Jun 14. pii: JVI.00805-17. doi: 10.1128/JVI.00805.
    PubMed     Abstract available

    May 2017
  186. WONG MT, Chen SS
    Hepatitis C Virus Subverts Human Choline Kinase-alpha to Bridge PI4KIIIalpha and NS5A and Upregulates PI4KIIIalpha Activation, Thereby Promoting the Translocation of the Ternary Complex to the ER for Viral Replication.
    J Virol. 2017 May 31. pii: JVI.00355-17. doi: 10.1128/JVI.00355.
    PubMed     Abstract available

  187. WU S, Zhao Q, Zhang P, Kulp J, et al
    Discovery and mechanistic study of benzamide derivatives that modulate hepatitis B virus capsid assembly.
    J Virol. 2017 May 31. pii: JVI.00519-17. doi: 10.1128/JVI.00519.
    PubMed     Abstract available

  188. LI Z, Li Y, Bi Y, Zhang H, et al
    Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.
    J Virol. 2017 May 24. pii: JVI.02227-16. doi: 10.1128/JVI.02227.
    PubMed     Abstract available

  189. SYED GH, Khan M, Yang S, Siddiqui A, et al
    Hepatitis C virus lipoviroparticles (HCV-LVP) assemble in the endoplasmic reticulum (ER) and bud off from the ER to Golgi in COPII vesicles.
    J Virol. 2017 May 17. pii: JVI.00499-17. doi: 10.1128/JVI.00499.
    PubMed     Abstract available

  190. DEVHARE PB, Sasaki R, Shrivastava S, Di Bisceglie AM, et al
    Correction for Devhare et al., "Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells".
    J Virol. 2017;91.

    April 2017
  191. FILSKOV J, Mikkelsen M, Hansen PR, Christensen JP, et al
    Broadening CD4+ and CD8+ T cell responses against hepatitis C virus by vaccination with NS3 overlapping peptide panels in cross-priming liposomes.
    J Virol. 2017 Apr 26. pii: JVI.00130-17. doi: 10.1128/JVI.00130.
    PubMed     Abstract available

  192. HSU SC, Lo CW, Pan TC, Lee KY, et al
    Serine 235 Is the Primary NS5A Hyper-Phosphorylation Site Responsible for HCV Replication.
    J Virol. 2017 Apr 26. pii: JVI.00194-17. doi: 10.1128/JVI.00194.
    PubMed     Abstract available

  193. FAN H, Qiao L, Kang KD, Fan J, et al
    Attachment and Post-Attachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.
    J Virol. 2017 Apr 12. pii: JVI.00280-17. doi: 10.1128/JVI.00280.
    PubMed     Abstract available

    January 2017
  194. WALTER S, Rasche A, Moreira-Soto A, Pfaender S, et al
    Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys.
    J Virol. 2016;91.
    PubMed     Abstract available

    October 2016
  195. LOGAN M, Law J, Wong JA, Hockman D, et al
    Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG.
    J Virol. 2016 Oct 19. pii: JVI.01552.
    PubMed     Abstract available

    July 2016
  196. DI SCALA M, Otano I, Gil-Farina I, Vanrell L, et al
    Complementary effects of IL-15 and IFN-alpha induce immunity in HBV transgenic mice.
    J Virol. 2016 Jul 20. pii: JVI.01030.
    PubMed     Abstract available

    June 2016
  197. MACPARLAND SA, Ma XZ, Chen L, Khattar R, et al
    Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
    J Virol. 2016;90:5549-60.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.